Jim Cramer - Mad Money Cal-Maine Foods Inc. CALM-Q DON'T BUY Apr 28, 2023

Stockchase Research Editor: Michael O'Reilly CALM produces and distributes eggs for sale to national grocery and food service companies. With more people cooking at home, sales have been strong -- up over 11% over the year and beating analyst expectations by 4%. EPS of $0.25, also beat expecations of a $0.08 loss. As restaurants re-open sales should grow further. Analysts expect the dividend to be re-instated soon. We would buy this with a stop-loss at $34, looking to achieve $47 -- just over 20% upside. Yield 0% (Analysts’ price target is $47.00)

Stockchase Research Editor: Michael O'Reilly CALM is the largest producer of regular shell and specialty eggs in the US. It carries no debt and has been growing its cash flow. They maintain a strong balance sheet by reducing the dividend following a quarterly financial loss. Recently reported EPS of $0.28 beat expectations of $0.07. The company announced a $0.034 dividend (implied payout ratio of 12%). We would buy this with a stop loss at $33, looking to achieve $47 -- upside potential over 20%. Yield 0.3% (Analysts’ price target is $47.00)

(A Top Pick Apr 01/21, Up 11.5%)Stockchase Research Editor: Michael O’Reilly Our PAST TOP PICK with CALM is progressing well. We now recommend trailing up the stop (from $33) to $39.

(A Top Pick Apr 01/21, Up 21.7%)Stockchase Research Editor: Michael O’Reilly Our PAST TOP PICK with CALM has achieved its $47 objective. To remain disciplined, we recommend covering half the position and trailing up the stop (from $39) to $42.

(A Top Pick Apr 01/21, Up 42%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CALM is progressing well. We now recommend trailing up the stop (from $42) to $50 at this time.

(A Top Pick Apr 01/21, Up 24.9%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MRK has triggered its stop at $50. To remain disciplined, we recommend covering half the position at this time. This will result in a net investment gain of 29%, when combined with the previous buy recommendation.